One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA. Zhang M, Lin C, Cai X, Jiao R, et al. Diabetes Obes Metab 2025;27:806-815.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang M, Lin C, Cai X, Jiao R, et al. One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA. Diabetes Obes Metab 2025;27:806-815.
PMID: 39568391